Skip to main content

Rebecca Gersnoviez Clifton

NIH Rank #65
  • Top 1% Funded
  • Program Leader
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9951276Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • BIOSTATISTICS & OTHER MATH SCI
  • Obstetrics & Gynecology

NIH Funding · FY2026

Linked Award Amount
$14.9M
Full award amounts, FY2026
Award Records
5
Records listing this PI
Award-Linked Rank
#65
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Rebecca Gersnoviez Clifton. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Rebecca Gersnoviez Clifton as a PI. Multi-PI records show the full award amount for context.

  • 5U24HD036801-29U24
    NICHD Maternal-Fetal Medicine Units (MFMU) Network: Data CoordinatingCenter
    $4M
    award amount
  • 5U01HD114634-03U01
    Adjunctive Azithromycin Prophylaxis for Scheduled/Prelabor Cesarean Delivery
    $3.4M
    award amount
  • 5U01HD114633-02U01
    Gestational hypertension and preeclampsia blood pressure (BP) Treatment goals <140/90 vs. <160/110 mmHg: The GOALPOST Trial
    $3.1M
    award amount
  • 5U01HD109332-03U01
    A Dose Escalation Study of Low Dose Aspirin for the Prevention of Recurrent Preterm Birth
    $2.5M
    award amount
  • 5U01HD118959-02U01
    Optimal Dosing of Understudied Drugs Administered to Pregnant Women per Standard of Care (PregDose)
    $1.9M
    award amount

Award organization

Organizations that administered FY2026 awards listing Rebecca Gersnoviez Clifton as a PI.

FY2026 award administered by George Washington University (DC).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    George Washington University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    Entered Top 50% Nationally
    Ranked #300
  8. 2024
    Entered Top 25% Nationally
    Ranked #300
  9. 2024
    Entered Top 10% Nationally
    Ranked #300
  10. 2024
    Entered Top 5% Nationally
    Ranked #300
  11. 2025
    Program/Center Grant Leader
  12. 2026
    $25M Cumulative Funding
  13. 2026
    Entered Top 1% Nationally
    Ranked #65
Rebecca Gersnoviez Clifton | NIH Award Records | ConductScience